Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein.

od Arispe, N, Rojas, E, Hartman, J, Sorscher, E J, Pollard, H B
Wydane 1992

S-palmitoylation regulates biogenesis of core glycosylated wild-type and F508del CFTR in a post-ER compartment

od McClure, M.L., Wen, H., Fortenberry, J., Hong, J.S., Sorscher, E.J.
Wydane 2014

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase

od Parker, W B, Allan, P W, Waud, W R, Hong, J S, Sorscher, E J
Wydane 2011

Antisense oligodeoxynucleotide to the cystic fibrosis gene inhibits anion transport in normal cultured sweat duct cells.

od Sorscher, E J, Kirk, K L, Weaver, M L, Jilling, T, Blalock, J E, LeBoeuf, R D
Wydane 1991

Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.

od Logan, J, Hiestand, D, Daram, P, Huang, Z, Muccio, D D, Hartman, J, Haley, B, Cook, W J, Sorscher, E J
Wydane 1994

Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats

od Plyler, Z.E., Birket, S.E., Schultz, B.D., Hong, J. S., Rowe, S.M., Petty, C.F., Crowley, M.R., Crossman, D.K., Schoeb, T.R., Sorscher, E.J.
Wydane w Mech Dev (2018)

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors(†)

od Rosenthal, E. L., Chung, T. K., Parker, W. B., Allan, P. W., Clemons, L., Lowman, D., Hong, J., Hunt, F. R., Richman, J., Conry, R. M., Mannion, K., Carroll, W. R., Nabell, L., Sorscher, E. J.
Wydane w Ann Oncol (2015)